Search results for "switching"

showing 10 items of 288 documents

Changes of QTc interval after opioid switching to oral methadone.

2013

Abstract A consecutive sample of patients who were switched from strong opioids to methadone in a period of 1 year was surveyed. QTc was assessed before switching (T0) and after achieving adequate analgesia and an acceptable level of adverse effects (Ts). Twenty-eight of 33 patients were switched to methadone successfully. The mean initial methadone doses at T0 were 67.1 mg/day (SD ±80.2, range 12-390). The mean QTc interval at T0 was 400 ms (SD ±30, range 330-450). The mean QTc interval at Ts (median 5 days) was 430 ms (SD ±26, range 390-500). The difference (7.7 %) was significant (p < 0.0005). Only two patients had a QTc of 500 ms. No serious arrhythmia was observed. At the linear regres…

MaleRiskCancer pain; Methadone; QT prolongation; Toxicity; Opioid switchingPainSettore MED/41 - AnestesiologiaQT prolongationSettore MED/42 - Igiene Generale E ApplicataQT intervalCONSECUTIVE SAMPLEElectrocardiographyNeoplasmsOpiate Substitution TreatmentmedicineHumansIn patientcardiovascular diseasesCancer painAdverse effectAgedToxicitybusiness.industryMiddle AgedAnalgesics OpioidLong QT SyndromeOncologyOpioidAnesthesiaToxicityLinear Modelscardiovascular systemOpioid switchingFemaleCancer painbusinessMethadoneMethadonemedicine.drug
researchProduct

Electrophysiological correlates of the cognitive control processes underpinning mixing and switching costs

2016

Typically, in task-switching contexts individuals are slower and less accurate when repeating a task in mixed blocks compared to single-task blocks (mixing cost) and when switching to a new task compared to repeating a previous one (switch cost). Previous research has shown that distinct electrophysiological correlates underlie these two phenomena. However, this evidence is not a consistent result. The goal of this study was to better characterize differences between the control processes involved in mixing and switch costs. To this aim, we examined event-related potentials (ERPs) evoked during a cued task-switching experiment. In order to minimize the confounding effects of cognitive deman…

MaleTask switchingTask-setElectroencephalographyCueTask (project management)Developmental psychologyExecutive Function0302 clinical medicineCognitionEvoked PotentialsMixing (physics)Cerebral Cortexmedicine.diagnostic_testGeneral Neuroscience05 social sciencesCognitionElectroencephalographyExecutive functionsexecutive functionsERP; cognitive control; executive functions; switch-positivity; task-set; task-switchingCognitive controlFemaleswitch-positivityCuesEvoked PotentialPsychologypsychological phenomena and processesERPCognitive psychologyHumanAdultTask switchingbehavioral disciplines and activities050105 experimental psychology03 medical and health sciencesYoung AdultP3bmedicineReaction TimeHumans0501 psychology and cognitive sciencesMolecular Biologytask-switchingCued speechNeuroscience (all)Settore M-PSI/02 - Psicobiologia E Psicologia FisiologicaSwitch positivityNeurology (clinical)030217 neurology & neurosurgeryPsychomotor PerformanceDevelopmental Biology
researchProduct

Positive affect and self-control: attention to self-control demands mediates the influence of positive affect on consecutive self-control.

2013

Positive affect (PA) can either improve or impair self-control performance, depending on whether two tasks are dissimilar, and thus require flexible releasing and switching, or similar, which requires stable maintenance. The present study suggests that this effect is mediated by attentional shifts. The authors found that participants under PA, who performed on two dissimilar tasks and had to switch to a new response dimension, were less attentive to distracting information compared to neutral affect (NE), leading to better performance. In contrast, participants under PA who did not have to switch, were more attentive to distracting information compared to participants under NE. These findin…

MaleTask switchingmedia_common.quotation_subjectExperimental and Cognitive PsychologySelf-controlSocial Control InformalAffect (psychology)Developmental psychologyAffectYoung AdultArts and Humanities (miscellaneous)Developmental and Educational PsychologyReaction TimeHumansAttentionFemalePsychologypsychological phenomena and processesPsychomotor Performancemedia_commonCognitive psychologyCognitionemotion
researchProduct

Opioid plasma concentration during switching from morphine to methadone: Preliminary data

2003

Opioid switching is often used to improve the opioid response in cancer patients experiencing poor analgesia or adverse effects. However, no data are available on plasmatic changes of opioids and their metabolites during these phases, and whether there exists a relationship with the clinical events. In a prospective study of 10 consecutive cancer patients on oral morphine but with uncontrolled pain (greater >4 on a numerical scale of 0 to 10) and/or moderate to severe opioid adverse effects (on a level of 2 and 3 of a verbal scale) and not responsive to adjuvant medications, switching to oral methadone was performed using a fixed ratio of 5:1, leaving extra-doses of 1/5 of the daily dose of…

MaleTime FactorsAdministration OralAdverse effectDrug Administration ScheduleNeoplasmsBlood plasmamedicineHumansProspective StudiesCancer painProspective studyProspective cohort studyAdverse effectAgedDose-Response Relationship DrugMorphinebusiness.industryMiddle AgedPain IntractableAnalgesics OpioidTreatment OutcomeOpioidOncologyAnesthesiaToxicitySwitchingMorphineFemaleAnalgesiabusinessCancer painMethadonemedicine.drugMethadone
researchProduct

Rapid Switching Between Transdermal Fentanyl and Methadone in Cancer Patients

2005

Purpose The aim of this study was to examine the clinical effects of switching from transdermal (TTS) fentanyl to methadone, or vice versa, in patients with a poor response to the previous opioid. Patients and Methods A prospective study was carried out on 31 patients who switched from TTS fentanyl to oral methadone, or vice versa, because of poor opioid response. A fixed conversion ratio of fentanyl to methadone of 1:20 was started and assisted by rescue doses of opioids, and then doses were changed according to clinical response. Pain and symptom intensity, expressed as distress score, were recorded before switching doses of the two opioids and after subsequent doses. The number of change…

Malecancer patientCancer ResearchPaincancer patients; rapid switching; transdermal fentanyl; methadone; prospective studyAdministration CutaneousFentanylNeoplasmsmedicineHumansIn patientProspective StudiesProspective cohort studyPain MeasurementTransdermalbusiness.industryCancerMiddle Agedmedicine.diseasetransdermal fentanylAnalgesics OpioidFentanylClinical trialrapid switchingTreatment OutcomeOncologyOpioidAnesthesiaFemalebusinessMethadoneprospective studymedicine.drugMethadoneJournal of Clinical Oncology
researchProduct

Paroxysmal atrial fibrillation and high degree AV block: use of single-lead VDDR pacing with mode switching.

1998

Dual chamber rate responsive pacing incorporating a mode switching option is increasingly used in patients with chronic paroxysmal atrial fibrillation and high degree AV block. Single-lead VDDR pacemakers have rarely used for this indication. The purpose of this study was to determine their reliability of atrial sensing during atrial fibrillation, the percentage of atrial synchronous ventricular pacing, and the behavior of the sinus rate outside the phases of atrial fibrillation. We studied ten patients with a single-lead VDDR pacemaker implanted for this indication. Follow-up visits were performed at predischarge and after 1, 3, 6, 12, 18, and 24 months. During the mean follow-up period of…

Malemedicine.medical_specialtyPacemaker ArtificialTime FactorsParoxysmal atrial fibrillationVentricular stimulationInternal medicineAtrial FibrillationMedicineHumansSinus rhythmIn patientcardiovascular diseasesbusiness.industryP waveCardiac Pacing ArtificialAtrial fibrillationGeneral MedicineMiddle Agedmedicine.diseaseHeart BlockSingle leadAnesthesiacardiovascular systemCardiologyMode switchingFemaleCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesPacing and clinical electrophysiology : PACE
researchProduct

Switching from oxycodone to methadone in advanced cancer patients

2012

The aim of this study was to prospectively evaluate the outcomes and the conversion ratio of switching from oxycodone to methadone in advanced cancer patients admitted to an acute palliative care unit.A prospective study was carried out on a cohort of consecutive sample of patients receiving oxycodone, who were switched for different reasons mainly because of an inconvenient balance between analgesia and adverse effects. An initial conversion ratio between oxycodone and methadone was 3.3:1. Intensity of pain and symptoms associated with opioid therapy were recorded, and a distress score (DS) was also calculated as a sum of symptom intensity. A successful switching was considered when the in…

Malemedicine.medical_specialtyPalliative careoxycodone switching; advanced cancer patients; trial clinicoTreatment outcomePainSettore MED/42 - Igiene Generale E Applicataadvanced cancer patientoxycodone switchingNeoplasmsmedicineHumansProspective StudiesProspective cohort studyAgedDose-Response Relationship Drugbusiness.industryPalliative CareMiddle AgedAdvanced cancerAnalgesics OpioidTreatment OutcomeOncologyAnesthesiaEmergency medicineFemaletrial clinicobusinessOxycodoneMethadoneOxycodoneMethadonemedicine.drugSupportive Care in Cancer
researchProduct

Outcome of opioid switching 4 weeks after discharge from a palliative care unit.

2011

Despite the favorable effects reported with opioid switching performed in a specialized unit in the short term, data on long-term basis are poor, particularly after discharging patients home or in other settings.The aim of this prospective study was to evaluate the long-term outcome of patients who were switched in an acute palliative care unit at a high volume of opioid switching. A consecutive sample of patients who underwent opioid substitution during admission in an acute palliative care unit were assessed for a period of 1 year. Patients were followed-up for 4 weeks after being discharged. Patients were contacted by phone or visited at the outpatient clinic 4 weeks after discharge. Epi…

Malemedicine.medical_specialtyPalliative carepalliative care unitPainSettore MED/42 - Igiene Generale E ApplicataCONSECUTIVE SAMPLEopioid switchingEpidemiologymedicineHumansOutpatient clinicProspective cohort studyAgedRetrospective StudiesDrug Substitutionbusiness.industryPalliative Careopioid switching; palliative care unit; epidemiologic studyGeneral MedicineMiddle AgedAfter dischargeAnalgesics OpioidOpioidAnesthesiaepidemiologic studyFemalebusinessCancer painFollow-Up Studiesmedicine.drug
researchProduct

Efficacy of switching between tumor necrosis factor-alfa inhibitors in psoriasis: results from the Italian Psocare registry

2014

Background: Some studies have shown that switching patients from one tumor necrosis factor (TNF)-alfa inhibitor to another may be beneficial when they have an inadequate response or an adverse event. Objective: We sought to assess the variables predicting the efficacy of the second TNF-alfa inhibitor in patients discontinuing the first TNF-alfa inhibitor. Methods: Data from all 5423 consecutive patients starting TNF-alfa inhibitor therapy for psoriasis between September 2005 and September 2010 who were included in the Italian Psocare registry were analyzed. Results: In 105 patients who switched to a second TNF-alfa inhibitor who had complete follow-up data, 75% improvement in the Psoriasis …

Maleprimary inefficacy75% improvement in the Psoriasis Area Severity Index score; PASI; PASI 75; Psoriasis Area Severity Index; TNF; biologics; efficacy; primary inefficacy; psoriasis; secondary loss of efficacy; switching; tumor necrosis factor; tumor necrosis factor-alfa inhibitors; Adult; Analysis of Variance; Antibodies Monoclonal; Antibodies Monoclonal Humanized; Cohort Studies; Confidence Intervals; Dose-Response Relationship Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Immunoglobulin G; Italy; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Proportional Hazards Models; Psoriasis; Receptors Tumor Necrosis Factor; Registries; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha; Young AdultSWITHCESefficacyTNFpsoriasis; psoriasis arthritis; pharmachological treatmentPASI 75Severity of Illness IndexReceptors Tumor Necrosis FactorEtanerceptCohort StudiesMonoclonalReceptorsSettore MED/35 - Malattie Cutanee E VenereeRegistriesHumanizedtumor necrosis factor-alfa inhibitors.switchingHazard ratioAntibodies MonoclonalMiddle AgedTreatment OutcomeItalyPredictive value of tests75% improvement in the Psoriasis Area Severity Index scoreFemaleDrugPsoriasis Area Severity IndexbiologicTNF-alphaAdultmedicine.medical_specialtytumor necrosis factorDermatology75% improvement in the Psoriasis Area Severity Index score; PASI; PASI 75; Psoriasis Area Severity Index; TNF; biologics; efficacy; primary inefficacy; psoriasis; secondary loss of efficacy; switching; tumor necrosis factor; tumor necrosis factor-alfa inhibitorsAntibodies Monoclonal Humanizedsecondary loss of efficacyRisk AssessmentAntibodiestumor necrosis factor-alfa inhibitorsDrug Administration ScheduleDose-Response RelationshipYoung AdultSettore MED/35Predictive Value of TestsInternal medicinePsoriasisSeverity of illnessmedicineConfidence IntervalsHumansPsoriasisbiologicsAdverse effectPsoriasis; TNF-alphaProportional Hazards ModelsRetrospective Studiespsoriasibiologics; efficacy; primary inefficacy; psoriasis; secondary loss of efficacy; switching; tumor necrosis factor-alfa inhibitors; Adalimumab; Adult; Analysis of Variance; Antibodies Monoclonal; Antibodies Monoclonal Humanized; Cohort Studies; Confidence Intervals; Dose-Response Relationship Drug; Drug Administration Schedule; Etanercept; Female; Follow-Up Studies; Humans; Immunoglobulin G; Infliximab; Italy; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Proportional Hazards Models; Psoriasis; Receptors Tumor Necrosis Factor; Registries; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult; 2708Analysis of Variancepharmachological treatmentDose-Response Relationship DrugProportional hazards modelbusiness.industrytumor necrosis factor-alfa inhibitorTumor Necrosis Factor-alphaPASIAdalimumabRetrospective cohort studypsoriasis arthritismedicine.diseaseConfidence intervalInfliximabSurgeryImmunoglobulin GMultivariate AnalysisANTI-TNFAbusiness2708Follow-Up Studies
researchProduct

Opioid switching in patients with advanced cancer followed at home. A retrospective analysis.

2013

Abstract CONTEXT: Opioid switching has been found to improve opioid responsiveness in different conditions. However, data on opioid switching performed at home are almost nonexistent, despite the fact that most patients are followed at home. OBJECTIVES: The aim of this retrospective survey was to determine frequency, indications, usefulness, and safety of opioid switching when treating advanced cancer-related pain in patients followed at home. METHODS: A retrospective review of data from patients with advanced cancer followed at home by three home care teams for a period of two years was performed. Patients who had their opioids switched were selected. Reasons for switching opioid doses and…

Maleretrospective studyComorbiditySettore MED/42 - Igiene Generale E Applicataadvanced cancer patientNeoplasmsRetrospective analysisPrevalenceOpioid switching; advanced cancer patients; retrospective studyCancer painProspective cohort studyNursing (all)2901 Nursing (miscellaneous)General NursingAnalgesicsDrug SubstitutionHome Care ServicesAnalgesics OpioidCausalitySurvival RateTreatment OutcomeItalyFemaleDrugmedicine.drugmedicine.medical_specialtyAnalgesicPainContext (language use)OpioidDose-Response RelationshipmedicineHumansIn patientIntensive care medicineAgedRetrospective StudiesDose-Response Relationship Drugbusiness.industryAdvanced cancerSurvival AnalysisCancer pain; home care; opioid switching; Aged; Analgesics Opioid; Causality; Comorbidity; Dose-Response Relationship Drug; Drug Substitution; Female; Home Care Services; Humans; Italy; Male; Neoplasms; Pain; Prevalence; Quality of Life; Retrospective Studies; Survival Analysis; Survival Rate; Treatment Outcome; Anesthesiology and Pain Medicine; Neurology (clinical); Nursing (all)2901 Nursing (miscellaneous)Anesthesiology and Pain MedicineOpioidEmergency medicineMorphineOpioid switchingQuality of LifeNeurology (clinical)home carebusinessJournal of pain and symptom management
researchProduct